Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00235001 · ClinicalTrials.gov registry record · Phase 4
Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension
A Phase 4 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
NCT00235001 is a Phase 4 study that has completed, run by Abbott. The registered enrollment target is 120 participants.
The verdict
NCT00235001, a Phase 4 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
Study Summary
This study will investigate antihypertensive activity and safety profile of Tarka in Russian hypertension patients by ambulatory blood pressure measurement (ABPM)
Interventions
- DRUG trandolapril/verapamil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2004-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00235001
The ClinicalTrials.gov registry entry for NCT00235001 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which trandolapril/verapamil is the first listed.
NCT00235001 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00235001 about?
NCT00235001 is a clinical study titled "Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension". This study will investigate antihypertensive activity and safety profile of Tarka in Russian hypertension patients by ambulatory blood pressure measurement (ABPM)
What is the current status of trial NCT00235001?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2004-06.
What interventions are being tested in trial NCT00235001?
The interventions under investigation include: trandolapril/verapamil (DRUG).
Who is sponsoring clinical trial NCT00235001?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.